The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global LV-Based Cell and Gene Therapy Products Market Research Report 2025
Synopsis
LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.
The global LV-Based Cell and Gene Therapy Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for LV-Based Cell and Gene Therapy Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for LV-Based Cell and Gene Therapy Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for LV-Based Cell and Gene Therapy Products in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of LV-Based Cell and Gene Therapy Products include Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, Orchard Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for LV-Based Cell and Gene Therapy Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LV-Based Cell and Gene Therapy Products.
The LV-Based Cell and Gene Therapy Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LV-Based Cell and Gene Therapy Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LV-Based Cell and Gene Therapy Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bluebird Bio
Thermo Fisher Scientific
Intas
BMS
Orchard Therapeutics
Segment by Type
CAR-T Therapy
Autologous CD34+ Cell Gene Therapy
Segment by Application
Hospital
Diagnostic and Testing Laboratories
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LV-Based Cell and Gene Therapy Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.
The global LV-Based Cell and Gene Therapy Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for LV-Based Cell and Gene Therapy Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for LV-Based Cell and Gene Therapy Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for LV-Based Cell and Gene Therapy Products in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of LV-Based Cell and Gene Therapy Products include Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, Orchard Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for LV-Based Cell and Gene Therapy Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LV-Based Cell and Gene Therapy Products.
The LV-Based Cell and Gene Therapy Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LV-Based Cell and Gene Therapy Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LV-Based Cell and Gene Therapy Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bluebird Bio
Thermo Fisher Scientific
Intas
BMS
Orchard Therapeutics
Segment by Type
CAR-T Therapy
Autologous CD34+ Cell Gene Therapy
Segment by Application
Hospital
Diagnostic and Testing Laboratories
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LV-Based Cell and Gene Therapy Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CAR-T Therapy
1.2.3 Autologous CD34+ Cell Gene Therapy
1.3 Market by Application
1.3.1 Global LV-Based Cell and Gene Therapy Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global LV-Based Cell and Gene Therapy Products Market Perspective (2019-2030)
2.2 Global LV-Based Cell and Gene Therapy Products Growth Trends by Region
2.2.1 Global LV-Based Cell and Gene Therapy Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 LV-Based Cell and Gene Therapy Products Historic Market Size by Region (2019-2024)
2.2.3 LV-Based Cell and Gene Therapy Products Forecasted Market Size by Region (2025-2030)
2.3 LV-Based Cell and Gene Therapy Products Market Dynamics
2.3.1 LV-Based Cell and Gene Therapy Products Industry Trends
2.3.2 LV-Based Cell and Gene Therapy Products Market Drivers
2.3.3 LV-Based Cell and Gene Therapy Products Market Challenges
2.3.4 LV-Based Cell and Gene Therapy Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LV-Based Cell and Gene Therapy Products Players by Revenue
3.1.1 Global Top LV-Based Cell and Gene Therapy Products Players by Revenue (2019-2024)
3.1.2 Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Players (2019-2024)
3.2 Global LV-Based Cell and Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by LV-Based Cell and Gene Therapy Products Revenue
3.4 Global LV-Based Cell and Gene Therapy Products Market Concentration Ratio
3.4.1 Global LV-Based Cell and Gene Therapy Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LV-Based Cell and Gene Therapy Products Revenue in 2023
3.5 Global Key Players of LV-Based Cell and Gene Therapy Products Head office and Area Served
3.6 Global Key Players of LV-Based Cell and Gene Therapy Products, Product and Application
3.7 Global Key Players of LV-Based Cell and Gene Therapy Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LV-Based Cell and Gene Therapy Products Breakdown Data by Type
4.1 Global LV-Based Cell and Gene Therapy Products Historic Market Size by Type (2019-2024)
4.2 Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Type (2025-2030)
5 LV-Based Cell and Gene Therapy Products Breakdown Data by Application
5.1 Global LV-Based Cell and Gene Therapy Products Historic Market Size by Application (2019-2024)
5.2 Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America LV-Based Cell and Gene Therapy Products Market Size (2019-2030)
6.2 North America LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
6.4 North America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LV-Based Cell and Gene Therapy Products Market Size (2019-2030)
7.2 Europe LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
7.4 Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size (2019-2030)
8.2 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024)
8.4 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LV-Based Cell and Gene Therapy Products Market Size (2019-2030)
9.2 Latin America LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
9.4 Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size (2019-2030)
10.2 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
10.4 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis LV-Based Cell and Gene Therapy Products Introduction
11.1.4 Novartis Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio LV-Based Cell and Gene Therapy Products Introduction
11.2.4 Bluebird Bio Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)
11.2.5 Bluebird Bio Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Introduction
11.3.4 Thermo Fisher Scientific Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Intas
11.4.1 Intas Company Details
11.4.2 Intas Business Overview
11.4.3 Intas LV-Based Cell and Gene Therapy Products Introduction
11.4.4 Intas Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)
11.4.5 Intas Recent Development
11.5 BMS
11.5.1 BMS Company Details
11.5.2 BMS Business Overview
11.5.3 BMS LV-Based Cell and Gene Therapy Products Introduction
11.5.4 BMS Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)
11.5.5 BMS Recent Development
11.6 Orchard Therapeutics
11.6.1 Orchard Therapeutics Company Details
11.6.2 Orchard Therapeutics Business Overview
11.6.3 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Introduction
11.6.4 Orchard Therapeutics Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)
11.6.5 Orchard Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CAR-T Therapy
Table 3. Key Players of Autologous CD34+ Cell Gene Therapy
Table 4. Global LV-Based Cell and Gene Therapy Products Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global LV-Based Cell and Gene Therapy Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global LV-Based Cell and Gene Therapy Products Market Share by Region (2019-2024)
Table 8. Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global LV-Based Cell and Gene Therapy Products Market Share by Region (2025-2030)
Table 10. LV-Based Cell and Gene Therapy Products Market Trends
Table 11. LV-Based Cell and Gene Therapy Products Market Drivers
Table 12. LV-Based Cell and Gene Therapy Products Market Challenges
Table 13. LV-Based Cell and Gene Therapy Products Market Restraints
Table 14. Global LV-Based Cell and Gene Therapy Products Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global LV-Based Cell and Gene Therapy Products Market Share by Players (2019-2024)
Table 16. Global Top LV-Based Cell and Gene Therapy Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LV-Based Cell and Gene Therapy Products as of 2023)
Table 17. Ranking of Global Top LV-Based Cell and Gene Therapy Products Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by LV-Based Cell and Gene Therapy Products Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of LV-Based Cell and Gene Therapy Products, Headquarters and Area Served
Table 20. Global Key Players of LV-Based Cell and Gene Therapy Products, Product and Application
Table 21. Global Key Players of LV-Based Cell and Gene Therapy Products, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Type (2019-2024)
Table 25. Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Type (2025-2030)
Table 27. Global LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Application (2019-2024)
Table 29. Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Application (2025-2030)
Table 31. North America LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis LV-Based Cell and Gene Therapy Products Product
Table 49. Novartis Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Bluebird Bio Company Details
Table 52. Bluebird Bio Business Overview
Table 53. Bluebird Bio LV-Based Cell and Gene Therapy Products Product
Table 54. Bluebird Bio Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)
Table 55. Bluebird Bio Recent Development
Table 56. Thermo Fisher Scientific Company Details
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product
Table 59. Thermo Fisher Scientific Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Intas Company Details
Table 62. Intas Business Overview
Table 63. Intas LV-Based Cell and Gene Therapy Products Product
Table 64. Intas Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)
Table 65. Intas Recent Development
Table 66. BMS Company Details
Table 67. BMS Business Overview
Table 68. BMS LV-Based Cell and Gene Therapy Products Product
Table 69. BMS Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)
Table 70. BMS Recent Development
Table 71. Orchard Therapeutics Company Details
Table 72. Orchard Therapeutics Business Overview
Table 73. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product
Table 74. Orchard Therapeutics Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)
Table 75. Orchard Therapeutics Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report
List of Figures
Figure 1. LV-Based Cell and Gene Therapy Products Picture
Figure 2. Global LV-Based Cell and Gene Therapy Products Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global LV-Based Cell and Gene Therapy Products Market Share by Type: 2023 VS 2030
Figure 4. CAR-T Therapy Features
Figure 5. Autologous CD34+ Cell Gene Therapy Features
Figure 6. Global LV-Based Cell and Gene Therapy Products Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global LV-Based Cell and Gene Therapy Products Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Diagnostic and Testing Laboratories Case Studies
Figure 10. Academic and Research Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. LV-Based Cell and Gene Therapy Products Report Years Considered
Figure 13. Global LV-Based Cell and Gene Therapy Products Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global LV-Based Cell and Gene Therapy Products Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global LV-Based Cell and Gene Therapy Products Market Share by Region: 2023 VS 2030
Figure 16. Global LV-Based Cell and Gene Therapy Products Market Share by Players in 2023
Figure 17. Global Top LV-Based Cell and Gene Therapy Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LV-Based Cell and Gene Therapy Products as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by LV-Based Cell and Gene Therapy Products Revenue in 2023
Figure 19. North America LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)
Figure 21. United States LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)
Figure 25. Germany LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Share by Region (2019-2030)
Figure 33. China LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)
Figure 41. Mexico LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)
Figure 45. Turkey LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)
Figure 49. Bluebird Bio Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)
Figure 51. Intas Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)
Figure 52. BMS Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)
Figure 53. Orchard Therapeutics Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
